August 27, 2012 — The growth rate of positron emission tomography (PET) and PET/computed tomography (CT) medical imaging ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
August 27, 2012 — Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master file ...
August 24, 2012 — West Physics Consulting, a national provider of medical and health physics consulting and testing ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
August 21, 2012 — The U.S. Food and Drug Administration (FDA) granted marketing approval for cfrQuant, coronary flow ...
August 20, 2012 — Positron Corp. announced the use of its Attrius system at Caring Heart and Brain Imaging Inc. of ...
August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
August 3, 2012 — FluoroPharma Medical Inc., a company specializing in the development of novel diagnostic imaging ...
When I was a kid, living in a mid-size Wisconsin town, my family would drive the mile or so from our home to the Lake ...
July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
The last 20 years have brought about great advances in breast cancer detection and treatment. Among them has been the ...
July 24, 2012 — Navidea Biopharmaceuticals Inc., a specialty pharmaceutical company focused on precision diagnostic ...
July 23, 2012 — GE Healthcare announced the final results from a Phase III study of the investigational PET (positron ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
July 13, 2012 — Royal Philips Electronics announced that it has embarked on a five-year joint research and development ...
June 20, 2012 — The Society of Nuclear Medicine’s (SNM) 2012 Image of the Year illustrates the effectiveness of Bi-213 ...
June 15, 2012 — Data presented at the Society for Nuclear Medicine (SNM) Annual Meeting shows that uptake of the ...
June 15, 2012 — Several groundbreaking studies on the Naviscan PET scanner, the breast application for which is positron ...
June 14, 2012 — Addicts unable to kick a cocaine habit could one day be vaccinated against cocaine and see proof with a ...
June 8, 2012 — At this year’s SNM Annual Meeting, June 9-13, Philips Healthcare is highlighting its portfolio of nuclear ...
June 4, 2012 — GE Healthcare signed an agreement with Affibody AB (“Affibody”) to collaborate on the development of a ...
June 4, 2012 — Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced Amyvid is available to imaging centers in ...
August 27, 2012 